Unexpected activity of two enzymes helps explain why liver cancer drugs fail

Researchers have discovered that lack of two types of enzymes can lead to liver disease and cancer in mice. In human liver tumors, they found that deficiencies in these two enzymes, Shp2 and Pten, are associated with poor prognosis. The study provides a new understanding of liver cancer development, new therapeutic approach and new mouse model for studying the disease.